Skip to main content

Opioid Use

5
Pipeline Programs
12
Companies
14
Clinical Trials
1 recruiting
3
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
5
Early DiscoveryClinical DevelopmentMarket

On Market (3)

Approved therapies currently available

BUPIVACAINE LIPOSOMEApproved
bupivacaine
Unknown Company
Amide Local Anesthetic [EPC]injection2024
EXPARELApproved
bupivacaine
Unknown Company
Amide Local Anesthetic [EPC]injection2011
POSIMIRApproved
bupivacaine
Unknown Company
infiltration2021

Competitive Landscape

12 companies ranked by most advanced pipeline stage

Spine BioPharma
Spine BioPharmaNY - New York
2 programs
1
Opioid AnalgesicPhase 41 trial
M-StimN/A1 trial
Active Trials
NCT04491175Completed160Est. May 2025
NCT04990804Terminated8Est. Feb 2022
iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
1 program
1
BupivacainePhase 41 trial
Active Trials
NCT03638635Terminated63Est. Jan 2019
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
Arm 1 Prescription As UsualN/A1 trial
BPAN/A1 trial
Active Trials
NCT04043143Completed57Est. Jan 2021
NCT04446975Completed21,689Est. Jun 2021
Masimo
MasimoIRVINE, CA
2 programs
Masimo SafetyNet AlertN/A1 trial
NSS-2 BRIDGEN/A1 trial
Active Trials
NCT06217380Terminated10Est. Feb 2024
NCT05506878Recruiting286Est. Sep 2026
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Information SheetN/A1 trial
Active Trials
NCT03179566Completed391Est. Sep 2017
Alliance Pharmaceuticals
1 program
Medical MarijuanaN/A1 trial
Active Trials
NCT04827992Completed87Est. Oct 2025
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Pericapsular Nerve BlockN/A1 trial
Active Trials
NCT06443892CompletedEst. Jul 2024
Design Therapeutics
1 program
SOONER Video & KitN/A1 trial
Active Trials
NCT04740099Withdrawn0Est. Mar 2023
Design Pharmaceuticals
1 program
SOONER Video & KitN/A
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
SuboxoneN/A1 trial
Active Trials
NCT05108935Completed17Est. Mar 2023
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
TACUNA plus Wellness CircleN/A1 trial
Active Trials
NCT04617938Completed541Est. Jul 2025
Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
TrainingN/A1 trial
Active Trials
NCT03821103Completed104Est. Feb 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Spine BioPharmaOpioid Analgesic
iNova PharmaceuticalsBupivacaine
MasimoMasimo SafetyNet Alert
City TherapeuticsPericapsular Nerve Block
MasimoNSS-2 BRIDGE
Spine BioPharmaM-Stim
Allergy TherapeuticsSuboxone
Design TherapeuticsSOONER Video & Kit
Alliance PharmaceuticalsMedical Marijuana
Angeles TherapeuticsTACUNA plus Wellness Circle
Colorado TherapeuticsBPA
Colorado TherapeuticsArm 1 Prescription As Usual
Shield TherapeuticsTraining
Human BioSciencesInformation Sheet

Clinical Trials (14)

Total enrollment: 23,413 patients across 14 trials

Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery

Start: Aug 2021Est. completion: Feb 20228 patients
Phase 4Terminated

Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients

Start: May 2018Est. completion: Jan 201963 patients
Phase 4Terminated
NCT06217380MasimoMasimo SafetyNet Alert

Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Start: Sep 2023Est. completion: Feb 202410 patients
N/ATerminated
NCT06443892City TherapeuticsPericapsular Nerve Block

Comparison of Pain Relief After Hip Fracture Surgery: Hip and Groin Nerve Block

Start: May 2023Est. completion: Jul 2024
N/ACompleted
NCT05506878MasimoNSS-2 BRIDGE

Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement

Start: Oct 2022Est. completion: Sep 2026286 patients
N/ARecruiting

Impact of DuoTherm on Opioid Use and Low Back Pain

Start: Jun 2022Est. completion: May 2025160 patients
N/ACompleted

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

Start: Feb 2022Est. completion: Mar 202317 patients
N/ACompleted

Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)

Start: Dec 2021Est. completion: Mar 20230
N/AWithdrawn

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Start: Aug 2021Est. completion: Oct 202587 patients
N/ACompleted
NCT04617938Angeles TherapeuticsTACUNA plus Wellness Circle

TACUNA (Traditions and Connections for Urban Native Americans)

Start: Nov 2020Est. completion: Jul 2025541 patients
N/ACompleted

Best Practice Alert for Opioid Prescribing

Start: Jul 2020Est. completion: Jun 202121,689 patients
N/ACompleted
NCT04043143Colorado TherapeuticsArm 1 Prescription As Usual

24-hour Oral Morphine Equivalent Based Opioid Prescribing After Surgery

Start: Oct 2019Est. completion: Jan 202157 patients
N/ACompleted

Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments

Start: Feb 2019Est. completion: Feb 2020104 patients
N/ACompleted

Pain and Medication Use Following Surgery

Start: Jun 2017Est. completion: Sep 2017391 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 23,413 patients
12 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.